Hexagon Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21
Closed -$2.38K 1767
2025
Q1
$2.38K Sell
21
-20
-49% -$2.14K ﹤0.01% 1356
2024
Q4
$4.33K Buy
41
+31
+310% +$3.33K ﹤0.01% 1240
2024
Q3
$1.08K Buy
10
+5
+100% +$546 ﹤0.01% 1325
2024
Q2
$543 Sell
5
-36
-88% -$4.24K ﹤0.01% 1320
2024
Q1
$5.41K Sell
41
-86
-68% -$10.7K ﹤0.01% 982
2023
Q4
$15.5K Buy
127
+37
+41% +$4.13K ﹤0.01% 721
2023
Q3
$10.1K Sell
90
-4
-4% -$508 ﹤0.01% 744
2023
Q2
$13.7K Buy
94
+85
+944% +$11.6K ﹤0.01% 669
2023
Q1
$1.16K Buy
9
+1
+13% +$126 ﹤0.01% 1161
2022
Q4
$1.02K Buy
+8
New +$928 ﹤0.01% 1205
2022
Q3
Sell
-5
Closed -$1K 1462
2022
Q2
$1K Hold
5
﹤0.01% 1149
2022
Q1
$1K Hold
5
﹤0.01% 903
2021
Q4
$1K Hold
5
﹤0.01% 837
2021
Q3
$1K Hold
5
﹤0.01% 838
2021
Q2
$1K Hold
5
﹤0.01% 797
2021
Q1
$0 Hold
5
﹤0.01% 802
2020
Q4
$0 Hold
5
﹤0.01% 763
2020
Q3
$0 Buy
+5
New +$653 ﹤0.01% 732

Other funds holding ZBH

Hexagon Capital Partners's ZBH Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 21 shares — an estimated $2.38K sold.

Hexagon Capital Partners first reported a position in ZBH in Q3 2020 and held it in 18 quarters. The position peaked at $15.5K in Q4 2023. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 21 Zimmer Biomet shares in Q2 2025, an estimated $2.38K.
  • Hexagon Capital Partners first reported a position in Zimmer Biomet in Q3 2020 and held it in 18 quarters.
  • Hexagon Capital Partners's Zimmer Biomet position peaked at $15.5K in Q4 2023.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.